Emerald Expands UCB Alliance

Xconomy Seattle — 

Emerald BioStructures, a biotech research firm on Bainbridge Island, WA, said today it has achieved the second milestone in a collaboration with Belgium-based UCB. The milestone, in which Emerald and UCB were able to identify new drug candidates to interact with some undisclosed protein structures, prompted the two sides to expand their collaboration, Emerald said. Financial terms of the new arrangement aren’t being disclosed, but the alliance provides enough to support “multiple full-time researcher equivalents at Emerald.” We wrote an in-depth story about Emerald’s recovery from the brink of bankruptcy back in May.